Health News

(Federation of American Societies for Experimental Biology) You may never hear fruit flies snore, but rest assured that when you’re asleep, they are too. According to research published in the January 2009 issue of the journal Genetics, scientists have shown that sleep/wake cycles of fruit flies and vertebrates are regulated by some of the same “cellular machinery” as humans. This is significant because the sleep-regulating enzyme that was analyzed is one of only a few possible drug targets for circadian problems.

Read more

Filed under: General Health News
Tags: Drug, General Health News, Genetic

Related posts

• Singapore research organisations team up to advance drug discovery using brain tumor stem cells (0)
  (Agency for Science, Technology and Research (A*STAR), Singapore) A new research collaboration will leverage earlier findings that primary brain tumors are caused by minority group of cells that display genetic profile distinct from that of tumor bulk. Read more [tags] General Health News [/tags]
  
  
• Scientists unmask genetic markers associated with psoriasis (0)
  (University of Michigan Health System) Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA "hotspots" that may reveal how genetic differences among individuals result in psoriasis, an autoimmune disease of the skin. Published in Nature Genetics, the findings could lead to new drug [...]
  
  
• Safe new therapy for genetic heart disease (0)
  (American Journal of Pathology) A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease. The related report by Penicka et al, "The effects of candesartan on left ventricular hypertrophy and function in non-obstructive hypertrophic cardiomyopathy: a pilot, randomized [...]
  
  
• Research increases possibilities of personalizing treatment of infant osteosarcoma (0)
  (Elhuyar Fundazioa) A team of specialists at the University Hospital of Navarra have revealed the existence of genetic variants that have greater resistance to a specific treatment and a greater toxicity of the pharmaceutical drug in some child patients affected by osteosarcoma. The team investigated the mechanisms of the illness in order to obtain a [...]
  
  
• Promising new drug being evaluated as possible treatment option for fragile X syndrome (0)
  (Rush University Medical Center) A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome. Findings of the open label, single-dose study by researchers at Rush University Medical Center and the University of California, Davis, [...]